← Evidence map

ArticlePharmaceutics2026

HPLC-MS Quantification of Multiple Tyrosine Kinase Inhibitors in Patients with Solid Tumors: Method Validation and Clinical Application.

Juliane Staudinger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

HPLC-MS Quantification of Multiple Tyrosine Kinase Inhibitors in Patients with Solid Tumors: Method Validation and Clinical Application. | OpenQuestion